Sign in

CIK 0000943819 · Large accelerated filer

Tickers
RMD RSMDF
Exchange
NYSE, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
980152841
Phone
8587462400
Business address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123

Securities

  • RMD ResMed Inc. Common Stock NYSE
  • RSMDF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,744,605
in 5 filings, $3.7M under 10b5-1 plans

Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-07-22 Sandercock Brett Chief Financial Officer Option exercise +2,500 $57.76 $144K 111,426
2022-07-22 Sandercock Brett Chief Financial Officer Option exercise +2,500 $57.76 $144K 113,926
2022-07-22 Sandercock Brett Chief Financial Officer Sale −7,500 $235.00 $1.8M 106,426
2022-07-22 Sandercock Brett Chief Financial Officer Option exercise · ResMed Common Stock Options −2,500 7,500
2022-07-22 Sandercock Brett Chief Financial Officer Option exercise · ResMed Common Stock Options −2,500 5,000
2022-07-22 Sandercock Brett Chief Financial Officer Option exercise · ResMed Common Stock Options −2,500 2,500
2022-07-15 Farrell Michael J. Chief Executive Officer Option exercise +5,675 $57.76 $328K 410,935
2022-07-15 Farrell Michael J. Chief Executive Officer Sale −5,675 $224.94 $1.3M 405,260
2022-07-15 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options −5,675 94,265
2022-07-05 PENDARVIS DAVID Chief Administrative Officer Sale −1,545 $212.33 $328K 106,831
2022-06-15 Farrell Michael J. Chief Executive Officer Option exercise +5,675 $57.76 $328K 410,935
2022-06-15 Farrell Michael J. Chief Executive Officer Sale −5,675 $202.54 $1.1M 405,260
2022-06-15 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options −5,675 99,940
2022-06-03 PENDARVIS DAVID Chief Administrative Officer Sale −1,545 $209.44 $324K 108,376
2022-05-16 Farrell Michael J. Chief Executive Officer Option exercise +5,675 $57.76 $328K 410,935
2022-05-16 Farrell Michael J. Chief Executive Officer Sale −5,675 $196.61 $1.1M 405,260
2022-05-16 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options −5,675 105,615
2022-05-03 PENDARVIS DAVID Chief Administrative Officer Sale −1,545 $200.00 $309K 109,858
2022-04-18 Farrell Michael J. Chief Executive Officer Option exercise +5,675 $57.76 $328K 410,904
2022-04-18 Farrell Michael J. Chief Executive Officer Sale −5,675 $232.41 $1.3M 405,229

Page 27 of 28 · 548 trades